Champions Oncolog
(CSBR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2004 | 04-2004 | 01-2004 | 10-2003 | 07-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 127 | 120 | 85 | 121 | 167 |
| Receivables | N/A | 23 | N/A | N/A | N/A |
| Inventories | 29 | 30 | 31 | 28 | 27 |
| TOTAL | $167 | $180 | $128 | $164 | $205 |
| Non-Current Assets | |||||
| PPE Net | 189 | 201 | 213 | 225 | 237 |
| Other Non-Current Assets | 11 | 11 | 11 | 11 | 11 |
| TOTAL | $200 | $212 | $224 | $236 | $248 |
| Total Assets | $367 | $392 | $352 | $401 | $453 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 92 | 93 | 61 | 74 | 66 |
| TOTAL | $489 | $592 | $492 | $504 | $709 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2 | 3 | 2 | 3 | 4 |
| TOTAL | $N/A | $N/A | $1 | $1 | $1 |
| Total Liabilities | $489 | $592 | $493 | $505 | $710 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 735 | 735 | 731 | 731 | 709 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -6,305 | -6,384 | -6,086 | -6,042 | -6,195 |
| Other shareholders' equity | 0 | 0 | 360 | 360 | 531 |
| TOTAL | $-122 | $-200 | $-140 | $-104 | $-257 |
| Total Liabilities And Equity | $367 | $392 | $352 | $401 | $453 |